ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
17.26
-0.14 (-0.80%)
Sep 19, 2025, 12:52 PM CET
STO:EXPRS2 Revenue
ExpreS2ion Biotech Holding AB had revenue of 3.42M SEK in the quarter ending June 30, 2025, with 42.46% growth. This brings the company's revenue in the last twelve months to 10.24M, up 26.49% year-over-year. In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M, down -11.07%.
Revenue (ttm)
10.24M
Revenue Growth
+26.49%
P/S Ratio
4.52
Revenue / Employee
512.15K
Employees
18
Market Cap
46.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.83M | -974.00K | -11.07% |
Dec 31, 2023 | 8.80M | 2.65M | 43.07% |
Dec 31, 2022 | 6.15M | -7.58M | -55.21% |
Dec 31, 2021 | 13.73M | -1.53M | -10.04% |
Dec 31, 2020 | 15.26M | 1.43M | 10.37% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.37B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |